Welcome to LookChem.com Sign In|Join Free
  • or
N6-(4-methoxybenzyl)quinazoline-2,4,6-triamine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

13919-69-2

Post Buying Request

13919-69-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13919-69-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 13919-69-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,9,1 and 9 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 13919-69:
(7*1)+(6*3)+(5*9)+(4*1)+(3*9)+(2*6)+(1*9)=122
122 % 10 = 2
So 13919-69-2 is a valid CAS Registry Number.

13919-69-2Downstream Products

13919-69-2Relevant academic research and scientific papers

Antileishmanial activity of quinazoline derivatives: Synthesis, docking screens, molecular dynamic simulations and electrochemical studies

Mendoza-Martínez, Cesar,Galindo-Sevilla, Norma,Correa-Basurto, Jose,Ugalde-Saldivar, Victor Manuel,Rodriguez-Delgado, Rosa Georgina,Hernández-Pineda, Jessica,Padierna-Mota, Cecilia,Flores-Alamo, Marcos,Hernandez-Luis, Francisco

, p. 314 - 331 (2015/03/05)

A series of quinazoline-2,4,6-triamine were synthesized and evaluated in vitro against Leishmania mexicana. Among them, N6-(ferrocenmethyl)quinazolin-2,4,6-triamine (H2) showed activity on pro-mastigotes and intracellular amastigotes, as well as low cytot

Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents

Mendoza-Martínez, César,Correa-Basurto, José,Nieto-Meneses, Rocío,Márquez-Navarro, Adrián,Aguilar-Suárez, Rocío,Montero-Cortes, Miriam Dinora,Nogueda-Torres, Benjamín,Suárez-Contreras, Erick,Galindo-Sevilla, Norma,Rojas-Rojas, ángela,Rodriguez-Lezama, Alejandro,Hernández-Luis, Francisco

, p. 296 - 307 (2015/04/27)

In this paper, the design, synthesis and biological evaluation of a set of quinazoline-2,4,6-triamine derivatives (1-9) as trypanocidal, antileishmanial and antiplasmodial agents are explained. The compounds were rationalized basing on docking studies of the dihydrofolate reductase (DHFR from Trypanosoma cruzi, Leishmania major and Plasmodium vivax) and pteridin reductase (PTR from T. cruzi and L. major) structures. All compounds were in vitro screened against both bloodstream trypomastigotes of T. cruzi (NINOA and INC-5 strains) and promatigotes of Leishmania mexicana (MHOM/BZ/61/M379 strain), and also for cytotoxicity using Vero cell line. Against T. cruzi, three compounds (5, 6 and 8) were the most effective showing a better activity profile than nifurtimox and benznidazole (reference drugs). Against L. mexicana, four compounds (5, 6, 8, and 9) exhibited the highest activity, even than glucantime (reference drug). In the cytotoxicity assay, protozoa were more susceptible than Vero cells. In vivo Plasmodium berghei assay (ANKA strain), the compounds 1, 5, 6 and 8 showed a more comparable activity than chloroquine and pyrimethamine (reference drugs) when they were administrated by the oral route. The antiprotozoal activity of these substances, endowed with redox properties, represented a good starting point for a medicinal chemistry program aiming for chemotherapy of Chagas' disease, leishmaniosis and malaria.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 13919-69-2